The product is purified from peripheral blood using immunomagnetic negative selection (depletion of other cell types). This approach is widely used when you want enriched cells while minimizing direct antibody capture of the target subset.
The cells are characterized by flow cytometry to support enrichment confirmation (the page references enrichment checks tied to CD14+ gating). This is helpful for aligning to your internal release criteria.
The large input cell number supports multi-arm differentiation designs (e.g., multiple cytokine cocktails, time-course harvests, replicate-heavy conditions) without forcing you to mix vials from different lots, which can introduce variability.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.